Sudeep Pharma Limited

NSE: SUDEEPPHRM · Healthcare

Overview

Sudeep Pharma Limited Share Price & Analysis

₹869.95▲ +0.40%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹869.95
+0.4%
Open
₹—
High
₹888.35
Low
₹858.55
Close
₹869.95
52W High
₹895
52W Low
₹524
Volume
108K
Lot Size
1
Sector
Healthcare
Market Cap
₹10K Cr
Face Value
₹1
Mid Cap

Price Chart

Fundamentals

P/E
56.4
Sector P/E
54.4
P/B
11.68
EPS
₹14.91
ROE
25.2%
ROCE
28.2%
D/E Ratio
0.17
Div Yield
0.17%
Book Value
₹78.2
+

Strengths

  • ✓Excellent return on equity (ROE 25.2%)
  • ✓Efficient capital deployment (ROCE 28.2%)
  • ✓Low debt relative to equity (D/E 0.2x)
−

Concerns

  • ✗High premium to book value (P/B 11.7x)
  • ✗Trading near 52-week high (₹895)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,944
₹4.6L Cr37.35.591620.50.07
DIVISLAB
Divi's Laboratories Limited
₹7,388
₹1.9L Cr73.411.7116.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
₹5,040
₹1.6L Cr73.620.3227.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹8,939
₹1.3L Cr64.913.5622.117.90.88
CIPLA
Cipla Limited
₹1,416
₹1.1L Cr30.13.3211.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
₹1,123
₹1.1L Cr214.1721.221.10.38
LUPIN
Lupin Limited
₹2,405
₹1.1L Cr19.64.928.729.90.32

Showing 7 peers in the same sector · Sorted by market cap

Corporate Events

Dividend - Rs 1.50 Per Share

Dividend22 Jul 2026

Latest News

All news →

Sudeep Pharma sets dividend record date for July 2026

*Sudeep Pharma sets dividend record date for July 2026.* The company has informed the exchange that the record date for dividend distribution is fixed at **23-Jul-2026**. This allows shareholders to determine eligibility for the proposed dividend. No details on dividend amount or payment date have been disclosed yet. 📊 *STOCKS:* SUDEEP | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Dividend

NSE Filing10 Jul
Low Impact

Sudeep Pharma releases annual report for FY25-26

*Sudeep Pharma releases annual report for FY25-26* — The company has shared its Integrated Annual Report with shareholders, detailing operational and financial performance. No major financial updates or strategic shifts were highlighted. The filing is part of routine corporate disclosure requirements. 📊 *STOCKS:* SUDEEPPHARM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AnnualReport

NSE Filing10 Jul
Low Impact

Sudeep Pharma to hold shareholder meeting on August 4, 2026

*Sudeep Pharma to hold shareholder meeting on August 4, 2026.* The meeting is scheduled for routine corporate matters. No specific agenda details disclosed yet. Such events typically involve approval of financials or board resolutions. 📊 *STOCKS:* SUDEEP | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholderMeeting

NSE Filing10 Jul
Low Impact

Sudeep Pharma IPO allotment finalized, listing details out

*Sudeep Pharma IPO allotment finalized, listing date announced.* Retail investors can check their allotment status on MUFG Intime India, NSE, and BSE. The stock is set to list on **November 22, 2023**, by **10:00 AM**. Shareholders received confirmation via email and SMS from RTA. 📊 *STOCKS:* SUDEEPPHARMA | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #IPO

Upstox3 Jul
Medium Impact

Financials

Quarterly Results

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue
₹182 Cr
▲5.8%
₹172 Cr
▲5.5%
₹163 Cr
▲30.4%
₹125 Cr
▼20.9%
₹158 Cr
▲36.2%
₹116 Cr
▼22.1%
₹149 Cr
Op. Profit
₹63 Cr
▲5.0%
₹60 Cr
▲9.1%
₹55 Cr
▲25.0%
₹44 Cr
▼25.4%
₹59 Cr
▲51.3%
₹39 Cr
▼38.1%
₹63 Cr
OPM
34.0%
▼2.9%
35.0%
▲2.9%
34.0%
▼2.9%
35.0%
▼5.4%
37.0%
▲8.8%
34.0%
▼20.9%
43.0%
Net Profit
₹49 Cr
▲2.1%
₹48 Cr
▲2.1%
₹47 Cr
▲51.6%
₹31 Cr
▼29.5%
₹44 Cr
▲51.7%
₹29 Cr
▼40.8%
₹49 Cr
EPS (₹)
4.33
▲3.1%
4.2
▼10.8%
4.71
▲48.6%
3.17
▼30.2%
4.54
▲53.9%
2.95
▼97.7%
128.13

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue
₹642 Cr
▲27.9%
₹502 Cr
▲9.4%
₹459 Cr
▲7.0%
₹429 Cr
▲25.1%
₹343 Cr
▲59.5%
₹215 Cr
▲74.8%
₹123 Cr
Expenses
₹419 Cr
▲35.2%
₹310 Cr
▲12.3%
₹276 Cr
▼18.3%
₹338 Cr
▲22.5%
₹276 Cr
▲61.4%
₹171 Cr
▲74.5%
₹98 Cr
Op. Profit
₹223 Cr
▲16.1%
₹192 Cr
▲4.9%
₹183 Cr
▲103.3%
₹90 Cr
▲34.3%
₹67 Cr
▲52.3%
₹44 Cr
▲76.0%
₹25 Cr
OPM
35.0%
▼7.9%
38.0%
▼5.0%
40.0%
▲90.5%
21.0%
▲5.0%
20.0%
▲0.0%
20.0%
▼4.8%
21.0%
Other Income
₹28 Cr
▲211.1%
₹9 Cr
▲50.0%
₹6 Cr
▼33.3%
₹9 Cr
▲28.6%
₹7 Cr
▲133.3%
₹3 Cr
▲0.0%
₹3 Cr
Interest
₹8 Cr
▲14.3%
₹7 Cr
▲40.0%
₹5 Cr
▼16.7%
₹6 Cr
▲200.0%
₹2 Cr
▲100.0%
₹1 Cr
▲0.0%
₹1 Cr
Depreciation
₹15 Cr
▲36.4%
₹11 Cr
▲22.2%
₹9 Cr
▲12.5%
₹8 Cr
▲60.0%
₹5 Cr
▲25.0%
₹4 Cr
▲33.3%
₹3 Cr
PBT
₹228 Cr
▲24.6%
₹183 Cr
▲4.6%
₹175 Cr
▲103.5%
₹86 Cr
▲24.6%
₹69 Cr
▲60.5%
₹43 Cr
▲72.0%
₹25 Cr
Tax %
24.0%
▲0.0%
24.0%
▲0.0%
24.0%
▼14.3%
28.0%
▲3.7%
27.0%
▲22.7%
22.0%
▼18.5%
27.0%
Net Profit
₹174 Cr
▲25.2%
₹139 Cr
▲4.5%
₹133 Cr
▲114.5%
₹62 Cr
▲24.0%
₹50 Cr
▲51.5%
₹33 Cr
▲83.3%
₹18 Cr
EPS (₹)
15.31
▲7.3%
14.27
▼98.5%
945.21
▲113.7%
442.27
▲24.2%
356.04
▲50.5%
236.6
▲84.8%
128.02
Div Payout
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Liabilities
Equity Capital
₹11 Cr
▲10.0%
₹10 Cr
▲900.0%
₹1 Cr
▲0.0%
₹1 Cr
▲0.0%
₹1 Cr
▲0.0%
₹1 Cr
▲0.0%
₹1 Cr
Reserves
₹872 Cr
▲81.3%
₹481 Cr
▲35.5%
₹355 Cr
▲59.9%
₹222 Cr
▲37.0%
₹162 Cr
▲43.4%
₹113 Cr
▲41.3%
₹80 Cr
Borrowings
₹150 Cr
▲7.1%
₹140 Cr
▲79.5%
₹78 Cr
▼6.0%
₹83 Cr
▼1.2%
₹84 Cr
▲171.0%
₹31 Cr
▲55.0%
₹20 Cr
Other Liabilities
₹141 Cr
▲64.0%
₹86 Cr
▲7.5%
₹80 Cr
▼29.2%
₹113 Cr
▲16.5%
₹97 Cr
▲44.8%
₹67 Cr
▲123.3%
₹30 Cr
Total Liabilities
₹1.2K Cr
▲63.7%
₹717 Cr
▲39.5%
₹514 Cr
▲22.4%
₹420 Cr
▲22.1%
₹344 Cr
▲61.5%
₹213 Cr
▲62.6%
₹131 Cr
Assets
Fixed Assets
₹337 Cr
▲78.3%
₹189 Cr
▲5.0%
₹180 Cr
▲13.9%
₹158 Cr
▲15.3%
₹137 Cr
▲101.5%
₹68 Cr
▲13.3%
₹60 Cr
CWIP
₹185 Cr
▲110.2%
₹88 Cr
▲95.6%
₹45 Cr
▲73.1%
₹26 Cr
▲225.0%
₹8 Cr
▼66.7%
₹24 Cr
▲200.0%
₹8 Cr
Investments
₹0 Cr
₹0 Cr
₹0 Cr
▼100.0%
₹3 Cr
₹0 Cr
▼100.0%
₹19 Cr
▲216.7%
₹6 Cr
Other Assets
₹652 Cr
▲48.5%
₹439 Cr
▲51.9%
₹289 Cr
▲24.6%
₹232 Cr
▲16.6%
₹199 Cr
▲95.1%
₹102 Cr
▲78.9%
₹57 Cr
Total Assets
₹1.2K Cr
▲63.7%
₹717 Cr
▲39.5%
₹514 Cr
▲22.4%
₹420 Cr
▲22.1%
₹344 Cr
▲61.5%
₹213 Cr
▲62.6%
₹131 Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating CF
₹70 Cr
▲42.9%
₹49 Cr
▼25.8%
₹66 Cr
▲37.5%
₹48 Cr
▲1700.0%
₹-3 Cr
▼108.6%
₹35 Cr
▲250.0%
₹10 Cr
Investing CF
₹-327 Cr
▼313.9%
₹-79 Cr
▼61.2%
₹-49 Cr
▲2.0%
₹-50 Cr
▼31.6%
₹-38 Cr
▲5.0%
₹-40 Cr
▼81.8%
₹-22 Cr
Financing CF
₹247 Cr
▲366.0%
₹53 Cr
▲507.7%
₹-13 Cr
▼30.0%
₹-10 Cr
▼119.6%
₹51 Cr
▲292.3%
₹13 Cr
▲8.3%
₹12 Cr
Net Cash Flow
₹-10 Cr
▼143.5%
₹23 Cr
▲475.0%
₹4 Cr
▲136.4%
₹-11 Cr
▼210.0%
₹10 Cr
▲25.0%
₹8 Cr
₹0 Cr
Free Cash Flow
₹-49 Cr
▼226.7%
₹-15 Cr
▼215.4%
₹13 Cr
▲1200.0%
₹1 Cr
▲101.3%
₹-77 Cr
▼420.8%
₹24 Cr
▲2300.0%
₹1 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debtor Days
129d
▼4.4%
135d
▲17.4%
115d
▲43.8%
80d
▼29.8%
114d
▲21.3%
94d
▲4.4%
90d
Inventory Days
356d
▲15.2%
309d
▲110.2%
147d
▲3.5%
142d
▲36.5%
104d
▲31.6%
79d
▲2.6%
77d
Days Payable
113d
▼22.1%
145d
▲29.5%
112d
▲45.5%
77d
▲1.3%
76d
▼3.8%
79d
▲12.9%
70d
Cash Conv. Cycle
372d
▲24.8%
298d
▲98.7%
150d
▲3.4%
145d
▲2.1%
142d
▲52.7%
93d
▼4.1%
97d
Working Capital Days
175d
▲21.5%
144d
▲45.5%
99d
▲7.6%
92d
▲206.7%
30d
▲130.8%
13d
▼71.7%
46d
ROCE
28.0%
▼22.2%
36.0%
▼26.5%
49.0%
▲48.5%
33.0%
▼8.3%
36.0%
▲0.0%
36.0%
—

Source: Screener.in · Lower days = better efficiency

Related Analysis

Same Sector

ALKEM
Alkem Laboratories Limited
Neutral
APOLLOHOSP
Apollo Hospitals Enterprise Limited
Neutral
AUROPHARMA
Aurobindo Pharma Limited
Neutral
BIOCON
Biocon Limited
Neutral
CIPLA
Cipla Limited
Neutral

Frequently Asked Questions

What is Sudeep Pharma Limited share price today?▾
Sudeep Pharma Limited (SUDEEPPHRM) is currently trading at ₹869.95 on NSE, up 0.40% as of the last market session. Prices update daily after market close on MarketNetra.
Is Sudeep Pharma Limited available in F&O (Futures & Options)?▾
Yes, Sudeep Pharma Limited (SUDEEPPHRM) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Sudeep Pharma Limited 52-week high and low?▾
Sudeep Pharma Limited's 52-week high is ₹895 and the 52-week low is ₹524. The current price of ₹869.95 is 2.8% below the 52W high.
What is Sudeep Pharma Limited P/E ratio?▾
Sudeep Pharma Limited's current P/E ratio is 56.4. This indicates the market is paying ₹56.4 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Sudeep Pharma Limited options?▾
Sudeep Pharma Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade SUDEEPPHRM options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.